281 related articles for article (PubMed ID: 31734174)
21. Genetic variations of NAT2 and CYP2E1 and isoniazid hepatotoxicity in a diverse population.
Yamada S; Tang M; Richardson K; Halaschek-Wiener J; Chan M; Cook VJ; Fitzgerald JM; Elwood RK; Brooks-Wilson A; Marra F
Pharmacogenomics; 2009 Sep; 10(9):1433-45. PubMed ID: 19761367
[TBL] [Abstract][Full Text] [Related]
22. NAT2 genetic polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in Chinese community population.
Lv X; Tang S; Xia Y; Zhang Y; Wu S; Yang Z; Li X; Tu D; Chen Y; Deng P; Ma Y; Chen D; Chen R; Zhan S
Ann Hepatol; 2012; 11(5):700-7. PubMed ID: 22947533
[TBL] [Abstract][Full Text] [Related]
23. Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity.
Singla N; Gupta D; Birbian N; Singh J
Tuberculosis (Edinb); 2014 May; 94(3):293-8. PubMed ID: 24637014
[TBL] [Abstract][Full Text] [Related]
24. Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil.
Possuelo LG; Castelan JA; de Brito TC; Ribeiro AW; Cafrune PI; Picon PD; Santos AR; Teixeira RL; Gregianini TS; Hutz MH; Rossetti ML; Zaha A
Eur J Clin Pharmacol; 2008 Jul; 64(7):673-81. PubMed ID: 18421452
[TBL] [Abstract][Full Text] [Related]
25. N-acetyltransferase 2, cytochrome P4502E1 and glutathione S-transferase genotypes in antitubercular treatment-induced hepatotoxicity in North Indians.
Rana SV; Sharma SK; Ola RP; Kamboj JK; Malik A; Morya RK; Sinha SK
J Clin Pharm Ther; 2014 Feb; 39(1):91-6. PubMed ID: 24188272
[TBL] [Abstract][Full Text] [Related]
26. N-acetyltransferase 2 (NAT2) genotype as a risk factor for development of drug-induced liver injury relating to antituberculosis drug treatment in a mixed-ethnicity patient group.
Ng CS; Hasnat A; Al Maruf A; Ahmed MU; Pirmohamed M; Day CP; Aithal GP; Daly AK
Eur J Clin Pharmacol; 2014 Sep; 70(9):1079-86. PubMed ID: 24888881
[TBL] [Abstract][Full Text] [Related]
27.
Mthiyane T; Millard J; Adamson J; Balakrishna Y; Connolly C; Owen A; Rustomjee R; Dheda K; McIlleron H; Pym AS
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964788
[TBL] [Abstract][Full Text] [Related]
28. N-acetyltransferase and cytochrome P450 2E1 gene polymorphisms and susceptibility to antituberculosis drug hepatotoxicity in an Indian population.
Mishra S; Daschakraborty S; Shukla P; Kapoor P; Aggarwal R
Natl Med J India; 2013; 26(5):260-5. PubMed ID: 25017831
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with anti-TB drug-induced hepatotoxicity and genetic polymorphisms in indigenous and non-indigenous populations in Brazil.
Heinrich MM; Zembrzuski VM; Ota MM; Sacchi FP; Teixeira RL; Cabello Acero PH; Cunha GM; Souza-Santos R; Croda J; Basta PC
Tuberculosis (Edinb); 2016 Dec; 101():15-24. PubMed ID: 27865386
[TBL] [Abstract][Full Text] [Related]
30. Association of Cytochrome P450 2E1 and N-Acetyltransferase 2 Genotypes with Serum Isoniazid Level and Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Cross-Sectional Study.
Pourmohamadi N; Pour Abdollah Toutkaboni M; Hayati Roodbari N; Tabarsi P; Baniasadi S
Iran J Med Sci; 2023 Sep; 48(5):474-483. PubMed ID: 37786472
[TBL] [Abstract][Full Text] [Related]
31. Distribution of allelic and genotypic frequencies of NAT2 and CYP2E1 variants in Moroccan population.
Guaoua S; Ratbi I; Laarabi FZ; Elalaoui SC; Jaouad IC; Barkat A; Sefiani A
BMC Genet; 2014 Dec; 15():156. PubMed ID: 25544508
[TBL] [Abstract][Full Text] [Related]
32. A case series of three patients presenting with isoniazid induced toxicity and N-acetyl transferase 2 gene mutation: A management conundrum for programmatic therapy of tuberculosis in India.
Shetty P; Panchal F; Munshi R; Sundar U; Darole P
Indian J Tuberc; 2020 Jul; 67(3):407-410. PubMed ID: 32825881
[TBL] [Abstract][Full Text] [Related]
33. tagSNP rs1495741 as a useful molecular marker to predict antituberculosis drug-induced hepatotoxicity.
Chamorro JG; Castagnino JP; Musella RM; Nogueras M; Frías A; Visca M; Aidar O; Costa L; de Larrañaga GF
Pharmacogenet Genomics; 2016 Jul; 26(7):357-61. PubMed ID: 27104815
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetic variability of tuberculosis biomarkers in native and mestizo Peruvian populations.
Jaramillo-Valverde L; Levano KS; Tarazona DD; Capristano S; Sanchez C; Poterico JA; Tarazona-Santos E; Guio H
Pharmacol Res Perspect; 2024 Jun; 12(3):e1179. PubMed ID: 38666760
[TBL] [Abstract][Full Text] [Related]
35. The association between CYP2E1 polymorphisms and hepatotoxicity due to anti-tuberculosis drugs: a meta-analysis.
Sheng YJ; Wu G; He HY; Chen W; Zou YS; Li Q; Zhong L; Huang YM; Deng CL
Infect Genet Evol; 2014 Jun; 24():34-40. PubMed ID: 24607341
[TBL] [Abstract][Full Text] [Related]
36. Genetic profile of the arylamine N-acetyltransferase 2 coding gene among individuals from two different regions of Brazil.
Teixeira RL; Miranda AB; Pacheco AG; Lopes MQ; Fonseca-Costa J; Rabahi MF; Melo HM; Kritski AL; Mello FC; Suffys PN; Santos AR
Mutat Res; 2007 Nov; 624(1-2):31-40. PubMed ID: 17509624
[TBL] [Abstract][Full Text] [Related]
37.
Mohamed Noor NF; Salleh MZ; Mohd Zim MA; Bakar ZA; Fakhruzzaman Noorizhab MN; Zakaria NI; Lailanor MI; Teh LK
Pharmacogenomics; 2022 Jun; 23(9):531-541. PubMed ID: 35615896
[No Abstract] [Full Text] [Related]
38. NAT2 and CYP2E1 polymorphisms and antituberculosis drug-induced hepatotoxicity in Peruvian patients.
Jaramillo-Valverde L; Levano KS; Tarazona DD; Capristano S; Zegarra-Chapoñan R; Sanchez C; Yufra-Picardo VM; Tarazona-Santos E; Ugarte-Gil C; Guio H
Mol Genet Genomic Med; 2022 Aug; 10(8):e1987. PubMed ID: 35751408
[TBL] [Abstract][Full Text] [Related]
39. Genetic polymorphisms of N-acetyltransferase 2 & susceptibility to antituberculosis drug-induced hepatotoxicity.
Sharma SK; Jha BK; Sharma A; Sreenivas V; Upadhyay V; Jaisinghani C; Singla R; Mishra HK; Soneja M
Indian J Med Res; 2016 Dec; 144(6):924-928. PubMed ID: 28474630
[TBL] [Abstract][Full Text] [Related]
40. The role of cigarette smoking and liver enzymes polymorphisms in anti-tuberculosis drug-induced hepatotoxicity in Brazilian patients.
Zaverucha-do-Valle C; Monteiro SP; El-Jaick KB; Rosadas LA; Costa MJ; Quintana MS; de Castro L
Tuberculosis (Edinb); 2014 May; 94(3):299-305. PubMed ID: 24793319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
